New Israeli cancer study leads to possible immunotherapy breakthrough
An Israeli-US team led by Weizmann Institute of Science researchers used a new data-driven approach to identify cancerous mutations that may be treatable with an off-the-shelf medicine.
A 3D immunofluorescent image of melanoma cells (magenta) infected with bacteria (turquoise); cell nuclei are blue(photo credit: WEIZMANN INSTITUTE OF SCIENCE)ByJERUSALEM POST STAFF